BR0303489A - Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound - Google Patents

Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound

Info

Publication number
BR0303489A
BR0303489A BR0303489A BR0303489A BR0303489A BR 0303489 A BR0303489 A BR 0303489A BR 0303489 A BR0303489 A BR 0303489A BR 0303489 A BR0303489 A BR 0303489A BR 0303489 A BR0303489 A BR 0303489A
Authority
BR
Brazil
Prior art keywords
ether compound
degradation
fluorine ether
inhibiting
inhibit
Prior art date
Application number
BR0303489A
Other languages
Portuguese (pt)
Inventor
Ogari De Castro Pacheco
Elisa Mannochio De Souza Russo
Valter Freire Torres Russo
Jose Antonio Martins
Maria Alice Bockelmann
Simone Soares Rosatto
Original Assignee
Cristalia Prod Quimicos Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cristalia Prod Quimicos Farm filed Critical Cristalia Prod Quimicos Farm
Priority to BR0303489A priority Critical patent/BR0303489A/en
Priority to ES04737744T priority patent/ES2289524T3/en
Priority to PCT/BR2004/000156 priority patent/WO2005023175A2/en
Priority to JP2006525578A priority patent/JP4253343B2/en
Priority to CN2004800211331A priority patent/CN1997360B/en
Priority to PT04737744T priority patent/PT1663186E/en
Priority to AT04737744T priority patent/ATE365034T1/en
Priority to EP04737744A priority patent/EP1663186B1/en
Priority to US10/566,466 priority patent/US7816409B2/en
Priority to DE602004007149T priority patent/DE602004007149T2/en
Priority to MXPA06000803A priority patent/MXPA06000803A/en
Priority to PL04737744T priority patent/PL1663186T3/en
Publication of BR0303489A publication Critical patent/BR0303489A/en
Priority to HK07113847.1A priority patent/HK1108633A1/en

Links

Abstract

"COMPOSIçãO FARMACêUTICA ESTABILIZADA DE COMPOSTO FLúOR-éTER E MéTODO PARA INIBIR A DEGRADAçãO DE COMPOSTO FLúOR-éTER. USO DE AGENTE ESTABILIZANTE PARA INIBIR A DEGRADAçãO DE COMPOSTO FLúOR éTER". A presente invenção tem como objetivo a estabilização de um composto flúor-éter contra a degradação proporcionada por ácidos de Lewis. Os estabilizantes empregados são selecionados dentre compostos farmacêuticos apropriados e são utilizados no preparo de composições farmacêuticas estabilizadas de um composto flúor-éter. São também descritos método de inibir a degradação de um composto flúor-éter e uso de agentes estabilizantes para inibir a degradação de um composto flúor-éter."STABILIZED PHARMACEUTICAL COMPOSITION OF FLUOR-ETHER COMPOUND AND METHOD FOR INHIBITING FLUOR-ETHER COMPOSITE DEGRADATION. USE OF STABILIZING AGENT TO INHIBIT FLUOR ETHER COMPOSITE DEGRADATION". The present invention aims at stabilizing a fluorine ether compound against the degradation provided by Lewis acids. The stabilizers employed are selected from the appropriate pharmaceutical compounds and are used in the preparation of stabilized pharmaceutical compositions of a fluorine ether compound. Also described are methods of inhibiting the degradation of a fluorine ether compound and use of stabilizing agents to inhibit the degradation of a fluorine ether compound.

BR0303489A 2003-09-10 2003-09-10 Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound BR0303489A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BR0303489A BR0303489A (en) 2003-09-10 2003-09-10 Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound
PT04737744T PT1663186E (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
PCT/BR2004/000156 WO2005023175A2 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
JP2006525578A JP4253343B2 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of anesthesia fluoroether compound, method for stabilizing fluoroether compound, use of stabilizer to prevent degradation of fluoroether compound
CN2004800211331A CN1997360B (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether com
ES04737744T ES2289524T3 (en) 2003-09-10 2004-08-20 STABLE PHARMACEUTICAL COMPOSITION OF A FLUOROETER COMPOSITE FOR ANESTHETIC USE, PROCEDURE FOR STABILIZING A FLUOROETER COMPOUND, USE OF A STABILIZING AGENT TO AVOID THE DEGRADATION OF A FLUOROETER COMPOUND.
AT04737744T ATE365034T1 (en) 2003-09-10 2004-08-20 STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZING AGENT TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND
EP04737744A EP1663186B1 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
US10/566,466 US7816409B2 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
DE602004007149T DE602004007149T2 (en) 2003-09-10 2004-08-20 A STABLE PHARMACEUTICAL COMPOSITION OF A FLUORETHER COMPOUND FOR ANESTHESIA, METHOD FOR STABILIZING A FLUORETHER COMPOUND, USE OF A STABILIZER TO EXCLUDE THE DEGRADATION OF A FLUORETHER COMPOUND
MXPA06000803A MXPA06000803A (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound.
PL04737744T PL1663186T3 (en) 2003-09-10 2004-08-20 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
HK07113847.1A HK1108633A1 (en) 2003-09-10 2007-12-19 Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0303489A BR0303489A (en) 2003-09-10 2003-09-10 Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound

Publications (1)

Publication Number Publication Date
BR0303489A true BR0303489A (en) 2005-07-05

Family

ID=34230439

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0303489A BR0303489A (en) 2003-09-10 2003-09-10 Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound

Country Status (2)

Country Link
CN (1) CN1997360B (en)
BR (1) BR0303489A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2244737T3 (en) * 2008-01-22 2019-07-08 Univ Texas Volatile anesthetic compositions comprising extraction solvents for regional anesthesia and / or pain relief
CN107950565B (en) * 2017-12-18 2021-06-29 青岛农业大学 Pesticide composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
DE60232178D1 (en) * 2001-08-29 2009-06-10 Pharmakodex Ltd DEVICE FOR TOPICAL ADMINISTRATION
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics

Also Published As

Publication number Publication date
CN1997360A (en) 2007-07-11
CN1997360B (en) 2010-08-04

Similar Documents

Publication Publication Date Title
BRPI0508579A (en) compound, pharmaceutical composition, and use of a compound
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
BRPI0415121A (en) particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form
BRPI0612104A8 (en) compound, diastereomeric mixture, pharmaceutical composition, and method for treating hepatitis c infections in a patient and for treating hcv infections in a patient
BRPI0509708A (en) pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and / or medium chain triglycerides
EA200802166A1 (en) STABLE PHARMACEUTICAL COMPOSITION WITH PROTECTIVE ACTION AGAINST IRRITATION (OPTIONS), METHOD FOR ITS PREPARATION AND METHOD OF TREATING CALCIUM MIMETIC WITH IT WITH HELP
BRPI0518781A2 (en) pharmaceutical formulation, process for preparing a pharmaceutical formulation, and use of a compound
HK1108633A1 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
MY197773A (en) Highly concentrated pharmaceutical formulations comprising anti-cd20 antibody
MX2009003735A (en) Injectable depot composition and its' process of preparation.
WO2006113631A3 (en) Bioenhanced compositions
BRPI0418270A (en) methods of treatment and control, treatment or prevention, control of a central nervous system disorder, and to reduce or prevent an adverse effect, and, pharmaceutical composition
PE20100265A1 (en) NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION
WO2005044234A3 (en) Nanoparticulate compositions having a peptide as a surface stabilizer
EP1750862A4 (en) Pharmaceutical composition containing irbesartan
BRPI0416260A (en) method for treating, preventing or controlling an asbestos-related disease or disorder and pharmaceutical composition
BR112022024943A2 (en) EFERVESCENT ORAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT
PE20080204A1 (en) PHARMACEUTICAL FORMULATIONS THAT INCLUDE AN ANTICHOLINERGIC AND A BETA AGONIST
ES2184310T3 (en) SELF-EMULSIONING FORMULATION FOR LIPOFIL ACID COMPOUNDS
BRPI0514250A (en) use of a compound, pharmaceutical composition comprising the same, compounds and method of treatment
MX2009003794A (en) Stabilized prostaglandin e composition.
DK1635792T3 (en) Stable pharmaceutical compositions of 2-aza-bicyclo-3.3.0-octane-3-carboxylic acid derivatives
BRPI0407652A (en) method for enhancing the effectiveness of an active agent, composition and method for producing the composition
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
BR0303489A (en) Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: BASEADO NO ART. 216 1 DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA.

B11K Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved

Free format text: REFERENCIA: PRIORIDADE INTERNA DO PI 0405842-9.